广西PCV13不同接种策略的经济学评价:决策树-Markov模型研究
本研究采用决策树-Markov模型,从社会视角模拟广西420000名出生队列儿童5年内自费接种与纳入免疫规划两种PCV13策略的健康经济影响。结果显示纳入免疫规划可提高接种覆盖、减少病例和死亡,ICER为6042.75美元/QALY,低于人均GDP阈值,概率敏感性分析显示成本效果概率接近100%。
要点
- 纳入免疫规划可大幅提高PCV13接种覆盖并减少肺炎球菌疾病负担。
- ICER为6042.75美元/QALY,低于人均GDP阈值,具成本效果。
- 概率敏感性分析显示成本效果概率接近100%,结果稳健。
核心结论
- 将PCV13纳入广西免疫规划具有高度成本效果,并可能产生正向经济回报。
研究设计与样本
- 采用决策树-Markov模型,从社会视角模拟420000名出生队列儿童5年内的健康经济结局。
- 比较当前自费接种策略与纳入国家免疫规划策略,成本和结局按3%贴现。
- 开展单因素和概率敏感性分析。
主要发现
- 纳入免疫规划使接种覆盖从5900人增至417019人。
- 预计5年内可预防77042例病例和327例死亡。
- 项目额外获得25702.2个QALY,ICER为6042.75美元/QALY。
- 概率敏感性分析显示大多数模拟低于支付意愿阈值,成本效果概率接近100%。
关键数值与推荐
- ICER为6042.75美元/QALY,低于人均GDP阈值。
- 接种覆盖从5900人增至417019人。
- 5年内预防77042例病例和327例死亡。
- 额外获得25702.2个QALY。
临床怎么用
- 研究结果为广西将PCV13纳入免疫规划的政策决策提供经济学证据支持。
- 决策者可参考ICER低于人均GDP阈值及高成本效果概率来优先配置疫苗资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pneumococcal disease remains a major cause of morbidity and mortality among children under five years of age, particularly in settings with low vaccine coverage. In China, the 13-valent pneumococcal conjugate vaccine (PCV13) is not included in the National Immunization Program (NIP), resulting in suboptimal uptake. This study evaluated the health and economic impact of including PCV13 in the immunization program in Guangxi Zhuang Autonomous Region. METHODS: A decision tree-Markov model was used to simulate a birth cohort of 420,000 children over a 5-year horizon from a societal perspective. The current self-paid vaccination strategy was compared with NIP inclusion. Outcomes included costs, cases, deaths, quality-adjusted life years (QALYs), incremental cost-effectiveness ratios (ICERs), and benefit-cost ratios (BCRs). Costs and outcomes were discounted at 3%. One-way and probabilistic sensitivity analyses were conducted. RESULTS: NIP inclusion increased vaccination coverage from 5900 to 417,019 children and was projected to prevent 77,042 cases and 327 deaths over 5 years. Despite higher vaccination costs, reduced disease burden resulted in a net economic benefit of USD 3.92 million (BCR: 1.03). The program generated an additional 25,702.2 QALYs, with an ICER of USD 6042.75 per QALY gained, below the per capita GDP threshold. Probabilistic sensitivity analysis showed that most simulations were below the willingness-to-pay threshold, with the probability of cost-effectiveness approaching 100%. CONCLUSIONS: Including PCV13 in Guangxi's immunization program is highly cost-effective and likely to yield positive economic returns. These findings are robust and support policy decisions on PCV13 inclusion.
引用
- He Q, Pang B, Su Z, et al. Economic evaluation of alternative PCV13 vaccination strategies in Guangxi, China: a decision tree-Markov model study. Vaccine. 2026. PMID: 42456563. doi:10.1016/j.vaccine.2026.128935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。